HGS launches "first" genomics product in clinic.
Marshall
A
A
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D018925:Chemokines / Q000235:genetics / Q000627:therapeutic use*; D019742:Chemokines, CC; D015195:Drug Design; D004357:Drug Synergism; D015723:Gene Library; D005818:Genetic Engineering / Q000379:methods*; D006801:Humans; D017387:Investigational New Drug Application; D009369:Neoplasms / Q000628:therapy; D013234:Stem Cells / Q000187:drug effects
D000970:Antineoplastic Agents; C105504:CCL23 protein, human; D018925:Chemokines; D019742:Chemokines, CC